Literature DB >> 16333655

False positive 18F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.

Kenichiro Hamada1, Takafumi Ueda, Yasuhiko Tomita, Ichiro Higuchi, Atsuo Inoue, Noriyuki Tamai, Akira Myoui, Katsuyuki Aozasa, Hideki Yoshikawa, Jun Hatazawa.   

Abstract

We report a rare case of chondroblastoma arising from the ischium which showed an increased (18)F-FDG uptake. Chondroblastoma is an uncommon lesion and usually involves the epiphysis of long bones. However, in this case, the tumor appeared as a well-defined osteolytic lesion in the ischium on radiographs. MR imaging demonstrated two components in the tumor: a solid one and a multilobular cystic component. (18)F-FDG PET imaging revealed an increased uptake in the ischium. The (18)F-FDG uptake resembled the results observed in malignant bone tumors. A histological diagnosis of chondroblastoma was obtained from tissue of an open biopsy. An immunohistochemical analysis demonstrated weak expression of both Glut-1 and HK-II. These findings suggest that Glut-1 and HK-II expression are not strongly related to FDG uptake in chondroblastoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333655     DOI: 10.1007/s00256-005-0032-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  23 in total

1.  Soft tissue aneurysmal bone cyst.

Authors:  X L Wang; J L Gielen; R Salgado; F Delrue; A M A De Schepper
Journal:  Skeletal Radiol       Date:  2004-05-19       Impact factor: 2.199

2.  Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice.

Authors:  R L Gamelli; H Liu; L K He; C A Hofmann
Journal:  J Leukoc Biol       Date:  1996-05       Impact factor: 4.962

Review 3.  Chondroblastoma of bone. A critical review.

Authors:  A G Huvos; R C Marcove
Journal:  Clin Orthop Relat Res       Date:  1973-09       Impact factor: 4.176

4.  The roentgenographic features of chondroblastoma.

Authors:  R A McLeod; J W Beabout
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1973-06

5.  FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.

Authors:  J Aoki; H Watanabe; T Shinozaki; K Takagishi; H Ishijima; N Oya; N Sato; T Inoue; K Endo
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

Review 6.  Alphabet soup: cystic lesions of bone.

Authors:  L M Parman; M D Murphey
Journal:  Semin Musculoskelet Radiol       Date:  2000       Impact factor: 1.777

7.  Recurrent and aggressive chondroblastoma of the pelvis with late malignant neoplastic changes.

Authors:  C V Reyes; S Kathuria
Journal:  Am J Surg Pathol       Date:  1979-10       Impact factor: 6.394

8.  Expression of cyclooxygenase-2 in chondroblastoma: immunohistochemical analysis with special emphasis on local inflammatory reaction.

Authors:  Koutaro Shinmura; Tsuyoshi Ishida; Takahiro Goto; Masahiko Kuroda; Hiroyuki Hattori; Shuzou Nagai; Tetsuo Imamura; Kiyoshi Mukai; Atsuhiro Imakiire
Journal:  Virchows Arch       Date:  2003-09-09       Impact factor: 4.064

9.  Chondroblastoma. A review of seventy cases.

Authors:  D S Springfield; R Capanna; F Gherlinzoni; P Picci; M Campanacci
Journal:  J Bone Joint Surg Am       Date:  1985-06       Impact factor: 5.284

10.  Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology.

Authors:  V Martinez; H A Sissons
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

View more
  2 in total

Review 1.  The imaging of cartilaginous bone tumours. I. Benign lesions.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-17       Impact factor: 2.199

2.  Dual-time-point FDG-PET/CT Imaging of Temporal Bone Chondroblastoma: A Report of Two Cases.

Authors:  Akira Toriihara; Atsunobu Tsunoda; Akira Takemoto; Kazunori Kubota; Youichi Machida; Ukihide Tateishi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.